InterAx platform is shortening the time and cost to discover new effective treatments and de-risk clinical trials. Our technology combines machine learning with mathematical modelling of cellular reactions and in-vitro laboratory experiments for the design and selection of better drugs.

Products, services, technology

Data sets of time-resolved assays are generated in-house and fed into mathematical models. We assess which critical properties a drug candidate must possess in order to elicit a desired cellular/clinical outcome and we provide suggestions for its chemical optimization.

Cooperation possibilities

We collaborate with Pharma to support their own drug discovery efforts. InterAx is open to different collaborative settings.

Location

5234 Villigen, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2016

  • Number of employees in Switzerland

    10-19

Key business